It was reported that KIF2C expression was significantly upregulated in HCC and breast cancer, and that KIF2C up-regulation was associated with a poor prognosis (Wei S. et al., 2020; Li T. et al., 2020). This evidence concerns the gene KIF2C and hepatocellular carcinoma.